First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination

The article presents a case of a 32-year-old male who developed IgA vasculitis (IgAV) and IgA vasculitis nephritis (IgAVN) after receiving the second dose of the AstraZeneca COVID-19 vaccine. IgAVN can be a rare side effect of COVID-19 vaccines. Healthcare providers should be aware of this potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Ortega, Jesús Iván, Perez-Hernandez, Felipe, Fernández-Reyna, Ilse, Eljure Lopez, Nixma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449366/
https://www.ncbi.nlm.nih.gov/pubmed/37637560
http://dx.doi.org/10.7759/cureus.42448
_version_ 1785094936640618496
author Martínez-Ortega, Jesús Iván
Perez-Hernandez, Felipe
Fernández-Reyna, Ilse
Eljure Lopez, Nixma
author_facet Martínez-Ortega, Jesús Iván
Perez-Hernandez, Felipe
Fernández-Reyna, Ilse
Eljure Lopez, Nixma
author_sort Martínez-Ortega, Jesús Iván
collection PubMed
description The article presents a case of a 32-year-old male who developed IgA vasculitis (IgAV) and IgA vasculitis nephritis (IgAVN) after receiving the second dose of the AstraZeneca COVID-19 vaccine. IgAVN can be a rare side effect of COVID-19 vaccines. Healthcare providers should be aware of this potential adverse event, and promptly recognize and manage it. However, the benefits of vaccination in reducing the morbidity and mortality associated with COVID-19 far outweigh the risks of this rare adverse event.
format Online
Article
Text
id pubmed-10449366
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104493662023-08-25 First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination Martínez-Ortega, Jesús Iván Perez-Hernandez, Felipe Fernández-Reyna, Ilse Eljure Lopez, Nixma Cureus Dermatology The article presents a case of a 32-year-old male who developed IgA vasculitis (IgAV) and IgA vasculitis nephritis (IgAVN) after receiving the second dose of the AstraZeneca COVID-19 vaccine. IgAVN can be a rare side effect of COVID-19 vaccines. Healthcare providers should be aware of this potential adverse event, and promptly recognize and manage it. However, the benefits of vaccination in reducing the morbidity and mortality associated with COVID-19 far outweigh the risks of this rare adverse event. Cureus 2023-07-25 /pmc/articles/PMC10449366/ /pubmed/37637560 http://dx.doi.org/10.7759/cureus.42448 Text en Copyright © 2023, Martínez-Ortega et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Martínez-Ortega, Jesús Iván
Perez-Hernandez, Felipe
Fernández-Reyna, Ilse
Eljure Lopez, Nixma
First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title_full First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title_fullStr First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title_full_unstemmed First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title_short First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination
title_sort first onset of iga vasculitis and nephritis following covid-19 vaccination
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449366/
https://www.ncbi.nlm.nih.gov/pubmed/37637560
http://dx.doi.org/10.7759/cureus.42448
work_keys_str_mv AT martinezortegajesusivan firstonsetofigavasculitisandnephritisfollowingcovid19vaccination
AT perezhernandezfelipe firstonsetofigavasculitisandnephritisfollowingcovid19vaccination
AT fernandezreynailse firstonsetofigavasculitisandnephritisfollowingcovid19vaccination
AT eljurelopeznixma firstonsetofigavasculitisandnephritisfollowingcovid19vaccination

Ejemplares similares